153 related articles for article (PubMed ID: 23223623)
1. Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis.
Viarisio D; Decker KM; Aengeneyndt B; Flechtenmacher C; Gissmann L; Tommasino M
J Gen Virol; 2013 Apr; 94(Pt 4):749-752. PubMed ID: 23223623
[TBL] [Abstract][Full Text] [Related]
2. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.
Viarisio D; Mueller-Decker K; Kloz U; Aengeneyndt B; Kopp-Schneider A; Gröne HJ; Gheit T; Flechtenmacher C; Gissmann L; Tommasino M
PLoS Pathog; 2011 Jul; 7(7):e1002125. PubMed ID: 21779166
[TBL] [Abstract][Full Text] [Related]
3. Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes.
Kang JK; Kim JH; Lee SH; Kim DH; Kim HS; Lee JE; Seo JS
Cancer Lett; 2000 Nov; 160(2):177-83. PubMed ID: 11053647
[TBL] [Abstract][Full Text] [Related]
4. Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice.
Viarisio D; Müller-Decker K; Accardi R; Robitaille A; Dürst M; Beer K; Jansen L; Flechtenmacher C; Bozza M; Harbottle R; Voegele C; Ardin M; Zavadil J; Caldeira S; Gissmann L; Tommasino M
PLoS Pathog; 2018 Jan; 14(1):e1006783. PubMed ID: 29324843
[TBL] [Abstract][Full Text] [Related]
5. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
Pacini L; Ceraolo MG; Venuti A; Melita G; Hasan UA; Accardi R; Tommasino M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724760
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.
Song S; Liem A; Miller JA; Lambert PF
Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610
[TBL] [Abstract][Full Text] [Related]
7. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.
Caldeira S; Zehbe I; Accardi R; Malanchi I; Dong W; Giarrè M; de Villiers EM; Filotico R; Boukamp P; Tommasino M
J Virol; 2003 Feb; 77(3):2195-206. PubMed ID: 12525654
[TBL] [Abstract][Full Text] [Related]
8. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.
Dong W; Kloz U; Accardi R; Caldeira S; Tong WM; Wang ZQ; Jansen L; Dürst M; Sylla BS; Gissmann L; Tommasino M
J Virol; 2005 Dec; 79(23):14899-908. PubMed ID: 16282489
[TBL] [Abstract][Full Text] [Related]
9. DMBA/TPA-induced tumor formation is aggravated in human papillomavirus type 16 E6/E7 transgenic mouse skin.
Kim MO; Kim SH; Shin MJ; Yu DH; Kim BS; Chang KT; Lee S; Park YB; Lee TH; Ryoo ZY
Oncol Res; 2007; 16(7):325-32. PubMed ID: 17518270
[TBL] [Abstract][Full Text] [Related]
10. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice.
Schaeffer AJ; Nguyen M; Liem A; Lee D; Montagna C; Lambert PF; Ried T; Difilippantonio MJ
Cancer Res; 2004 Jan; 64(2):538-46. PubMed ID: 14744767
[TBL] [Abstract][Full Text] [Related]
11. Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.
Young MR; Farrell L; Lambert P; Awasthi P; Colburn NH
Mol Carcinog; 2002 Jun; 34(2):72-7. PubMed ID: 12112313
[TBL] [Abstract][Full Text] [Related]
12. Novel ß-HPV49 Transgenic Mouse Model of Upper Digestive Tract Cancer.
Viarisio D; Müller-Decker K; Zanna P; Kloz U; Aengeneyndt B; Accardi R; Flechtenmacher C; Gissmann L; Tommasino M
Cancer Res; 2016 Jul; 76(14):4216-25. PubMed ID: 27216183
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
14. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
Song S; Pitot HC; Lambert PF
J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis.
Maufort JP; Williams SM; Pitot HC; Lambert PF
Cancer Res; 2007 Jul; 67(13):6106-12. PubMed ID: 17616666
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
[TBL] [Abstract][Full Text] [Related]
17. Human papillomaviruses and carcinogenesis: well-established and novel models.
Viarisio D; Gissmann L; Tommasino M
Curr Opin Virol; 2017 Oct; 26():56-62. PubMed ID: 28778034
[TBL] [Abstract][Full Text] [Related]
18. HPV and skin carcinogenesis.
Tommasino M
Papillomavirus Res; 2019 Jun; 7():129-131. PubMed ID: 30953864
[TBL] [Abstract][Full Text] [Related]
19. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.
Michel A; Kopp-Schneider A; Zentgraf H; Gruber AD; de Villiers EM
J Virol; 2006 Nov; 80(22):11153-64. PubMed ID: 16971438
[TBL] [Abstract][Full Text] [Related]
20. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.
Simonson SJ; Difilippantonio MJ; Lambert PF
Cancer Res; 2005 Sep; 65(18):8266-73. PubMed ID: 16166303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
